{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T18:24:15Z","timestamp":1779301455142,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03217-4","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T12:57:37Z","timestamp":1722257857000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessing the genetic associations between plasma lipidomic profiles and psoriasis vulgaris"],"prefix":"10.1007","volume":"316","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0362-6725","authenticated-orcid":false,"given":"Min","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4444-9884","authenticated-orcid":false,"given":"Shanshan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,29]]},"reference":[{"key":"3217_CR1","doi-asserted-by":"publisher","unstructured":"Ghoreschi K, Balato A, Enerb\u00e4ck C et al Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis [J]. Lancet,2021,397(10275): 754\u2013766. https:\/\/doi.org\/10.1016\/s0140-6736(21)00184-7","DOI":"10.1016\/s0140-6736(21)00184-7"},{"issue":"8","key":"3217_CR2","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1001\/jamadermatol.2021.2007","volume":"157","author":"AW Armstrong","year":"2021","unstructured":"Armstrong AW, Mehta MD, Schupp CW et al (2021) Psoriasis prevalence in adults in the United States [J]. JAMA Dermatol 157(8):940\u2013946. https:\/\/doi.org\/10.1001\/jamadermatol.2021.2007","journal-title":"JAMA Dermatol"},{"key":"3217_CR3","doi-asserted-by":"publisher","unstructured":"Parisi R, Symmons DP, Griffiths CE et al Global epidemiology of psoriasis: a systematic review of incidence and prevalence [J]. J Invest Dermatol 2013, 133(2): 377\u2013385. https:\/\/doi.org\/10.1038\/jid.2012.339","DOI":"10.1038\/jid.2012.339"},{"key":"3217_CR4","doi-asserted-by":"publisher","unstructured":"Griffiths CE, Barker JN Pathogenesis and clinical features of psoriasis [J]. Lancet, 2007,370(9583): 263\u2013271. https:\/\/doi.org\/10.1016\/s0140-6736(07)61128-3","DOI":"10.1016\/s0140-6736(07)61128-3"},{"key":"3217_CR5","doi-asserted-by":"publisher","unstructured":"Langley RG, Krueger GG, Griffiths CE Psoriasis: epidemiology, clinical features, and quality of life [J]. Ann Rheum Dis, 2005,64(Suppl 2): ii18-23; discussion ii24-15. https:\/\/doi.org\/10.1136\/ard.2004.033217","DOI":"10.1136\/ard.2004.033217"},{"key":"3217_CR6","doi-asserted-by":"publisher","unstructured":"Greb JE, Goldminz AM, Elder JT et al Psoriasis [J]. Nat Rev Dis Primers 2016, 2: 16082. https:\/\/doi.org\/10.1038\/nrdp.2016.82","DOI":"10.1038\/nrdp.2016.82"},{"key":"3217_CR7","doi-asserted-by":"publisher","unstructured":"Neimann AL, Shin DB, Wang X et al Prevalence of cardiovascular risk factors in patients with psoriasis [J]. J Am Acad Dermatol 2006, 55(5): 829\u2013835. https:\/\/doi.org\/10.1016\/j.jaad.2006.08.040","DOI":"10.1016\/j.jaad.2006.08.040"},{"key":"3217_CR8","doi-asserted-by":"publisher","unstructured":"Armstrong AW, Harskamp CT, Armstrong EJ Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis [J]. JAMA Dermatol ,2013,149(1): 84\u201391. https:\/\/doi.org\/10.1001\/2013.jamadermatol.406","DOI":"10.1001\/2013.jamadermatol.406"},{"key":"3217_CR9","doi-asserted-by":"publisher","unstructured":"Armstrong AW, Harskamp CT, Armstrong EJ The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies [J]. Nutr Diabetes 2012, 2(12): e54. https:\/\/doi.org\/10.1038\/nutd.2012.26","DOI":"10.1038\/nutd.2012.26"},{"key":"3217_CR10","doi-asserted-by":"publisher","unstructured":"Gisondi P, Fostini AC, Foss\u00e0 I et al Psoriasis and the metabolic syndrome [J]. Clin Dermatol 2018, 36(1): 21\u201328. https:\/\/doi.org\/10.1016\/j.clindermatol.2017.09.005","DOI":"10.1016\/j.clindermatol.2017.09.005"},{"key":"3217_CR11","doi-asserted-by":"publisher","unstructured":"Cao H, Su S, Yang Q et al Metabolic profiling reveals interleukin-17A monoclonal antibody treatment ameliorate lipids metabolism with the potentiality to reduce cardiovascular risk in psoriasis patients [J]. Lipids Health Dis 2021, 20(1): 16. https:\/\/doi.org\/10.1186\/s12944-021-01441-9","DOI":"10.1186\/s12944-021-01441-9"},{"key":"3217_CR12","doi-asserted-by":"publisher","unstructured":"Akhyani M, Ehsani AH, Robati RM et al The lipid profile in psoriasis: a controlled study [J]. J Eur Acad Dermatol Venereol 2007, 21(10): 1330\u20131332. https:\/\/doi.org\/10.1111\/j.1468-3083.2007.02260.x","DOI":"10.1111\/j.1468-3083.2007.02260.x"},{"key":"3217_CR13","doi-asserted-by":"publisher","unstructured":"Zhou Q, Jin X, Li H et al Cholesterol and low-density lipoprotein as a cause of psoriasis: results from bidirectional mendelian randomization [J]. J Eur Acad Dermatol Venereol 2024, 38(4): 710\u2013718. https:\/\/doi.org\/10.1111\/jdv.19670","DOI":"10.1111\/jdv.19670"},{"key":"3217_CR14","doi-asserted-by":"publisher","unstructured":"Xiao Y, Jing D, Tang Z et al Serum lipids and risk of Incident Psoriasis: a prospective cohort study from the UK Biobank Study and mendelian randomization analysis [J]. J Invest Dermatol 2022, 142(12): 3192\u20133199e3112. https:\/\/doi.org\/10.1016\/j.jid.2022.06.015","DOI":"10.1016\/j.jid.2022.06.015"},{"key":"3217_CR15","doi-asserted-by":"publisher","unstructured":"Ma C, Schupp CW, Armstrong EJ et al Psoriasis and dyslipidemia: a population-based study analyzing the National Health and Nutrition Examination Survey (NHANES) [J]. J Eur Acad Dermatol Venereol 2014, 28(8): 1109\u20131112. https:\/\/doi.org\/10.1111\/jdv.12232","DOI":"10.1111\/jdv.12232"},{"key":"3217_CR16","doi-asserted-by":"publisher","unstructured":"Shih CM, Chen CC, Chu CK et al The roles of lipoprotein in psoriasis [J]. Int J Mol Sci 2020, 21(3): 859. https:\/\/doi.org\/10.3390\/ijms21030859","DOI":"10.3390\/ijms21030859"},{"key":"3217_CR17","doi-asserted-by":"publisher","unstructured":"Liebisch G, Fahy E, Aoki J et al Update on LIPID MAPS classification, nomenclature, and shorthand notation for MS-derived lipid structures [J]. J Lipid Res 2020, 61(12): 1539\u20131555. https:\/\/doi.org\/10.1194\/jlr.S120001025","DOI":"10.1194\/jlr.S120001025"},{"key":"3217_CR18","doi-asserted-by":"publisher","unstructured":"Ottensmann L, Tabassum R, Ruotsalainen SE et al Genome-wide association analysis of plasma lipidome identifies 495 genetic associations [J]. Nat Commun 2023, 14(1): 6934. https:\/\/doi.org\/10.1038\/s41467-023-42532-8","DOI":"10.1038\/s41467-023-42532-8"},{"key":"3217_CR19","doi-asserted-by":"publisher","unstructured":"Sakaue S, Kanai M, Tanigawa Y et al A cross-population atlas of genetic associations for 220 human phenotypes [J]. Nat Genet 2021, 53(10): 1415\u20131424. https:\/\/doi.org\/10.1038\/s41588-021-00931-x","DOI":"10.1038\/s41588-021-00931-x"},{"key":"3217_CR20","doi-asserted-by":"publisher","unstructured":"Zhang ZY, Jian ZY, Tang Y et al The relationship between blood lipid and risk of psoriasis: univariable and multivariable Mendelian randomization analysis [J]. Front Immunol,2023,14: 1174998. https:\/\/doi.org\/10.3389\/fimmu.2023.1174998","DOI":"10.3389\/fimmu.2023.1174998"},{"key":"3217_CR21","doi-asserted-by":"publisher","unstructured":"Zhao SS, Yiu ZZN, Barton A et al Association of lipid-lowering drugs with risk of Psoriasis: a mendelian randomization study [J]. JAMA Dermatol 2023, 159(3): 275\u2013280. https:\/\/doi.org\/10.1001\/jamadermatol.2022.6051","DOI":"10.1001\/jamadermatol.2022.6051"},{"key":"3217_CR22","doi-asserted-by":"publisher","unstructured":"Zeng C, Wen B, Hou G et al Lipidomics profiling reveals the role of glycerophospholipid metabolism in psoriasis [J]. Gigascience,2017,6(10): 1\u201311. https:\/\/doi.org\/10.1093\/gigascience\/gix087","DOI":"10.1093\/gigascience\/gix087"},{"key":"3217_CR23","doi-asserted-by":"publisher","unstructured":"\u0141uczaj W, Dobrzy\u0144ska I, Wro\u0144ski A et al Cannabidiol-mediated changes to the Phospholipid Profile of UVB-Irradiated keratinocytes from psoriatic patients [J]. Int J Mol Sci 2020, 21(18). https:\/\/doi.org\/10.3390\/ijms21186592","DOI":"10.3390\/ijms21186592"},{"key":"3217_CR24","doi-asserted-by":"publisher","unstructured":"Paolino G, Buratta S, Mercuri SR et al Lipidic Profile changes in Exosomes and Microvesicles Derived from plasma of monoclonal antibody-treated psoriatic patients [J]. Front Cell Dev Biol 2022, 10: 923769. https:\/\/doi.org\/10.3389\/fcell.2022.923769","DOI":"10.3389\/fcell.2022.923769"},{"key":"3217_CR25","doi-asserted-by":"publisher","unstructured":"Deng S, Zhou G, Li X et al The impacts of biologic treatment on metabolic profiling in psoriasis [J]. Exp Dermatol 2024, 33(1): e15011. https:\/\/doi.org\/10.1111\/exd.15011","DOI":"10.1111\/exd.15011"},{"key":"3217_CR26","doi-asserted-by":"publisher","unstructured":"Karapetyan S, Davtyan H, Khachikyan K et al Impact of supplemental essential phospholipids on treatment outcome and quality of life of patients with psoriasis with moderate severity [J]. Dermatol Ther 2022, 35(4): e15335. https:\/\/doi.org\/10.1111\/dth.15335","DOI":"10.1111\/dth.15335"},{"key":"3217_CR27","doi-asserted-by":"publisher","unstructured":"Dai D, He C, Wang S et al Toward personalized interventions for Psoriasis Vulgaris: Molecular Subtyping of patients by using a Metabolomics Approach [J]. Front Mol Biosci 2022, 9: 945917. https:\/\/doi.org\/10.3389\/fmolb.2022.945917","DOI":"10.3389\/fmolb.2022.945917"},{"key":"3217_CR28","doi-asserted-by":"publisher","unstructured":"Greve AM, Wulff AB, Bojesen SE et al Elevated plasma triglycerides increase risk of psoriasis: a cohort and mendelian randomization study [J]. Br J Dermatol ,2024. https:\/\/doi.org\/10.1093\/bjd\/ljae089","DOI":"10.1093\/bjd\/ljae089"},{"issue":"3","key":"3217_CR29","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/bjd.12101","volume":"168","author":"C Ma","year":"2013","unstructured":"Ma C, Harskamp CT, Armstrong EJ et al (2013) The association between psoriasis and dyslipidaemia: a systematic review [J]. Br J Dermatol 168(3):486\u2013495. https:\/\/doi.org\/10.1111\/bjd.12101","journal-title":"Br J Dermatol"},{"key":"3217_CR30","doi-asserted-by":"publisher","unstructured":"Nowowiejska J, Baran A, Flisiak I Aberrations in lipid expression and metabolism in psoriasis [J]. Int J Mol Sci 2021, 22(12). https:\/\/doi.org\/10.3390\/ijms22126561","DOI":"10.3390\/ijms22126561"},{"key":"3217_CR31","doi-asserted-by":"publisher","unstructured":"Zhang X, Li X, Wang Y et al Abnormal lipid metabolism in epidermal langerhans cells mediates psoriasis-like dermatitis [J]. JCI Insight,2022,7(13). https:\/\/doi.org\/10.1172\/jci.insight.150223","DOI":"10.1172\/jci.insight.150223"},{"key":"3217_CR32","doi-asserted-by":"publisher","unstructured":"Mallbris L, Granath F, Hamsten A et al Psoriasis is associated with lipid abnormalities at the onset of skin disease [J]. J Am Acad Dermatol 2006, 54(4): 614\u2013621. https:\/\/doi.org\/10.1016\/j.jaad.2005.11.1079","DOI":"10.1016\/j.jaad.2005.11.1079"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03217-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03217-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03217-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T16:04:33Z","timestamp":1729699473000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03217-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,29]]},"references-count":32,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["3217"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03217-4","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,29]]},"assertion":[{"value":"13 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our work utilized publicly available data. Neither patient consent nor ethical approval was required for the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"494"}}